Comparison of the American Joint Committee on Cancer N1 versus N2a nodal categories for predicting survival and recurrence in patients with oral cancer: Time to acknowledge an arbitrary distinction and modify the system

Head and Neck

Volumn 38, Issue 1, 2016, Pages 135-139

  Ebrahimi, Ardalan ^a,b,c   Gil, Ziv ^d   Amit, Moran ^d   Yen, Tzu Chen ^e   Liao, Chun Ta ^e   Chatturvedi, Pankaj ^f   Agarwal, Jaiprakash ^f   Kowalski, Luiz ^g   Kreppel, Matthias ^h   Cernea, Claudio ⁱ   Brandao, Jose ⁱ   Bachar, Gideon ^j   Villaret, Andrea Bolzoni ^k   Fliss, Dan ^l   Fridman, Eran ^l   Robbins, K Thomas ^m   Shah, Jatin ⁿ   Patel, Snehal ⁿ   Clark, Jonathan ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^e CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^f TATA MEMORIAL HOSPITAL   (India)

^g A C CAMARGO CANCER CENTER   (Brazil)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ UNIVERSITY OF SÃO PAULO   (Brazil)

^j RABIN MEDICAL CENTER   (Israel)

^k UNIVERSITY OF BRESCIA   (Italy)

^l TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^m SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

more..

Author keywords

cancer staging; head and neck neoplasms; lymph node metastases; oral squamous cell carcinoma; prognosis

Indexed keywords

CETUXIMAB;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE STUDY; DISEASE SPECIFIC SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MULTICENTER STUDY (TOPIC); OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; AUSTRALIA; BRAZIL; CARCINOMA, SQUAMOUS CELL; CLINICAL TRIAL; FOLLOW UP; GERMANY; INDIA; ISRAEL; ITALY; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MOUTH NEOPLASMS; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; TAIWAN; TUMOR RECURRENCE; UNITED STATES;

AGED; AUSTRALIA; BRAZIL; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INDIA; ISRAEL; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; TAIWAN; UNITED STATES;

EID: 84955643895     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23871     Document Type: Article

References (12)

1. American Joint Committee for Cancer Staging and End Results Reporting: Manual for Staging of Cancer. Chicago, IL: American Joint Committee; 1977.
2. Hall SF, Groome PA, Dixon PF,. Does N stage predict survival? J Otolaryngol 1996; 25: 296-299.
3. Edge SB, Byrd DR, Compton C, Fritz AG, Greene FL, Trotti A III, editors. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2010.
4. Groome PA, Schulze K, Boysen M, Hall SF, Mackillop WJ,. A comparison of published head and neck stage groupings in carcinomas of the oral cavity. Head Neck 2001; 23: 613-624.
5. Hall SF, Groome PA, Irish J, O'Sullivan B,. TNM-based stage groupings in head and neck cancer: application in cancer of the hypopharynx. Head Neck 2009; 31: 1-8.
6. Kreppel M, Drebber U, Rothamel D, et al., Prognostic impact of different TNM-based stage groupings for oral squamous cell carcinoma. Head Neck 2011; 33: 1467-1475.
7. Manikantan K, Sayed SI, Syrigos KN, et al., Challenges for the future modifications of the TNM staging system for head and neck cancer: case for a new computational model? Cancer Treat Rev 2009; 35: 639-644.
8. Hall SF, Groome PA, Rothwell D, Dixon PF,. Using TNM staging to predict survival in patients with squamous cell carcinoma of head & neck. Head Neck 1999; 21: 30-38.
9. Bataini JP, Bernier J, Jaulerry C, Brunin F, Pontvert D,. Impact of cervical disease and its definitive radiotherapeutic management on survival: experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx. Laryngoscope 1990; 100: 716-723.
10. Stukel TA, Demidenko E, Dykes J, Karagas MR,. Two-stage methods for the analysis of pooled data. Stat Med 2001; 20: 2115-2130.
11. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
12. Higgins JP, Thompson SG,. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.